Show simple item record

dc.contributor.authorSorkhabi, R
dc.contributor.authorTaheri, N
dc.date.accessioned2018-08-26T08:28:21Z
dc.date.available2018-08-26T08:28:21Z
dc.date.issued2008
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/51485
dc.description.abstractPurpose: To describe a case of acute angle-closure glaucoma associated with oral topiramate (Topamax, Aria Daroo) therapy Case report: Two weeks after initiation of oral topiramate therapy for epilepsy, a 35-year-old woman presented with blurred vision and headache. Intraocular pressure in both eyes was significantly elevated and her visual acuity was 20/30 Ocular Uterque (OU). Bilateral conjunctival chemosis, shallow anterior chamber and mild corneal edema were observed. Topiramate therapy was discontinued. Topical therapy was initiated in both eyes with betamethasone, atropine and timolol Results: Symptoms and signs including vision accuracy, refraction and intraocular pressure resolved over the next 2 weeks. Conclusion: Topiramate therapy may be associated with ciliochoroidal effusion resulting in angle-closure glaucoma; therefore, patients on such therapy should be carefully monitored.
dc.language.isoEnglish
dc.relation.ispartofIRANIAN JOURNAL OF OPHTHALMOLOGY
dc.subjecttopiramate
dc.subjectangle-closure glaucoma
dc.subjectciliochoroidal effusion
dc.titleTopiramate induced bilateral angle-closure glaucoma
dc.typeArticle
dc.citation.volume20
dc.citation.issue3
dc.citation.spage49
dc.citation.epage52
dc.citation.indexWeb of science


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record